Cogent Biosciences (COGT) Net Cash Flow: 2017-2024
Historic Net Cash Flow for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $44.9 million.
- Cogent Biosciences' Net Cash Flow fell 85.11% to $16.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$22.4 million, marking a year-over-year decrease of 111.40%. This contributed to the annual value of $44.9 million for FY2024, which is 151.11% up from last year.
- Cogent Biosciences' Net Cash Flow amounted to $44.9 million in FY2024, which was up 151.11% from -$87.9 million recorded in FY2023.
- Over the past 5 years, Cogent Biosciences' Net Cash Flow peaked at $204.8 million during FY2020, and registered a low of -$87.9 million during FY2023.
- Over the past 3 years, Cogent Biosciences' median Net Cash Flow value was -$79.8 million (recorded in 2022), while the average stood at -$40.9 million.
- Per our database at Business Quant, Cogent Biosciences' Net Cash Flow skyrocketed by 1,222.19% in 2020 and then slumped by 254.56% in 2022.
- Yearly analysis of 5 years shows Cogent Biosciences' Net Cash Flow stood at $204.8 million in 2020, then crashed by 110.99% to -$22.5 million in 2021, then crashed by 254.56% to -$79.8 million in 2022, then declined by 10.17% to -$87.9 million in 2023, then skyrocketed by 151.11% to $44.9 million in 2024.